Selective MMP-12 inhibitors: WO-2008057254

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.19, Iss.7, 2009-07, pp. : 1029-1034

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MMP-12 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1637-1640

Informa Healthcare

Access to resources Recommend Favorite

Phosphinic Peptide Inhibitors of Macrophage Metalloelastase (MMP-12). Selectivity and Mechanism of Binding

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 967-976

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of WO2012032067 and WO2012055846: two selective PI3Kδ inhibitors, which is GSK-2269557?

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 965-970

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of WO2012037204 and WO2012037226: Exelixis' selective PI3Kδ inhibitors; the basis of a US$251 million deal

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 971-976

Informa Healthcare

Access to resources Recommend Favorite

A Quantitative Structure-Activity Relationship Study on a Series of Selective Non-zinc Binding Inhibitors of MMP13

Medicinal Chemistry, Vol. 10, Iss. 2, 2014-03 ,pp. : 174-188

Bentham Science Publishers

Access to resources Recommend Favorite